総説・レビュー

• 田中　良明，井上　大輔，津吉　秀昭，吉田　好雄
  「婦人科がんにおける栄養評価指標の有用性と今後」
  日本女性栄養・代謝学会会誌　第30巻1号

報告論文

• 吉田　好雄　
  3.支持・緩和委員会　支持・緩和医療委員会報告　
  第22回婦人科悪性腫瘍研究機構年次会議（総会）記録集　2024.6.30　ｐ42-43

学術原著論文

• J.Takahashi, M.Orisaka, D.Inoue, H.Kawamura, N.Takahashi, H.Tsuyoshi, A.Shinagawa, T.Kurokawa, Y.Yoshida.
  Evaluation of the holding-up uterus technique for placenta accreta spectrum cesarean hysterectomy in shocked patients with a high shock index: a case series study.
  BMC Surg. 2024 Jan 13;24(1):23. doi: 10.1186/s12893-024-02311-8.PMID: 38218800
• Felicia Roncolato , Madeleine T King , Rachel L O'Connell , Yeh Chen Lee , Florence Joly , Felix Hilpert , Anne Lanceley , Y.Yoshida , Jane Bryce , Paul Donnellan , Amit Oza , ElisabethAvallLundqvist, JonathanSBerek , JonathanALedermann , DominiqueBerton , Jalid Sehouli , Marie-Christine Kaminsky , Martin R Stockler , Michael Friedlander
  Hidden in plain sight-Survival consequences of baseline symptom burden in women with recurrent ovarian cancer
  Gynecol Oncol　　2024.2　　26（185）　　ｐ128-137
  doi: 10.1016/j.ygyno.2024.02.025　　　PMID: 38412736
• T.Ito, T.Onuma, T.Kurokawa, Y.Chino, A.Shinagawa,Y.Yoshida
  Evaluating Opt-In Vaginal Human Papillomavirus Self-Sampling: Participation Rates and Detection of High-Grade Lesions (CIN2+) among Unscreened Japanese Women Aged 30–39
  Healthcare 2024 (MDPI) 12(5) 599
  PMID: 38470710 　DOI: 10.3390/healthcare12050599
• H.Hoshino, Ya-Ying Chen, D.Inoue, Y.Yosida, Kay-Hooi Khoo, T O .Akama, M.Kobayashi
  Expression of low-sulfated keratan sulfate in non-mucinous ovarian carcinoma
  Glycobiology. 2024Mar19 34(1) cwad056
• H.Hoshino, D.Inoue, A.Shinagawa, H.Yoshida, S.Shigeto, K.Matsuda, T O .Akama, Y .Yoshida, M.Kobayashi.
  Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA.Hum Cell. 37（4）　ｐ1184-1193　PMID:
  38573494　DOI: 10.1007/s13577-024-01058-x　　 (IF=4.37) 2024 Apr 4.
• D.Inoue, H.Hoshino, Chen YY, M.Yamamoto, A.Kogami, M.Fukushima, Khoo KH, Akama TO, Y.Yoshida, M.Kobayashi.
  Structural Elucidation and Prognostic Relevance of 297-11A-Sulfated Glycans in Ovarian Carcinoma.　
  Lab Invest.　 2024 Apr 4;　104(6):102057　（IF＝５）
• S.Hosokawa, Y.Norimatsu, A.Shinagawa, T.Kurokawa, Y.Yoshida, T.Nishikawa, H.Suzuki, S.Irino, TK. Kobayashi
  Assessment of the localization of chondroitin sulfate in various types of endometrial carcinoma.　
  PLoS One.　 2024 May 28;19(5):e0304420. （IF＝3.75）
• T.Onuma, M.Asare-Werehene, Y.Fujita, Y.Yoshida , BK.Tsang
  Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer
  Cells　2024.3.24；13（11）ｐ905　　doi: 10.3390/cells13110905.　(IF=6)
• T.Onuma, A.Shinagawa, T.Kurokawa, M.Orisaka, Y.Yoshida.　
  Fractal Dimension, Circularity, and Solidity of Cell Clusters in Liquid-Based Endometrial Cytology Are Potentially Useful for Endometrial Cancer Detection and Prognosis Prediction.　
  Cancers (Basel). 2024 Jul 6;　16(13):2469
• Y.Miyazaki, M.Orisaka, Y.Fujita, T.Mizutani, T.Yazawa, Y.Yoshida.
  Steroidogenic differentiation of human amniotic membrane-derived mesenchymal stem cells into a progesterone-/androgen-producing cell lineage by SF-1 and an estrogen-producing cell lineage by WT1-KTS.
  Front Endocrinol (Lausanne). 2024 Sep 18;　15:1410433.
  doi: 10.3389/fendo.2024.1410433.　 eCollection 2024.
• K.Hasegawa,S.Takahashi, K.Ushijima, M.Okadome,K.Yonemori, H.Yokota, lgnase Vergote, Bradley J Monk, Krishnansu S Tewari, K.Fjiwara, Jingjin Li, Shaheda Jamil, Anne Paccaly, K.Takehara, T.Usami, Y.Aoki, N.Suzuki, Y.Kobayashi, Y.Yshida, H.Watari, Frank Seebach, lsrael Lowy, Melissa Mathias, Matthew G Fury, Ana Oaknin
  Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
  Cancer Med 2024Sep; 13(18) e70236
• Y.Tanaka, D.Inoue, H.Tsuyoshi, Y.Nakamura, M.Kato, M.Kato, K.Niwa, K.Yashiro, M.Orisaka, Y.Yoshida
  Usefulness of Nutritional Assessment Indicators in Predicting Treatment from Discontinuation Dur to Adverse Events from PARP Inhibitors in Ovarian Cancer Patients
  Cancers 2024Oct25 16(21) p3602
• Y.Chino, T.Onuma, T.Ito, A.Shinagawa, T.Kurokawa, M.Orisaka, Y.Yoshida
  Human Papillomavirus Self-Sampling for Unscreened WomenAged 24Years During the COVID-19 Pandemic
  Healthcare (Basel) 2024 Oct 30;12(21):2160.

症例報告

• S.Yamada, M.Orisaka, T.Kurokawa, T.Onuma, A.Shinagawa, Y.Yshida
  Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report
  J Obstet Gynaecol Res. 2024 Aug 18　ｐ1748-1752　　
• S.Yamada,M.Orisaka,T.Kurokawa,T.Onuma,A.Shinagawa,Y.Yoshida
  combination therapy with paclitaxel and trastuzumab for humanepidermal growth factor receptor　2-positive recurrent serous carcinoma of the uterine cervix:A case report
  J Obstet and Gynaecol Res 　　2024 Sep;50(9): p1748-1752
• Y.Myazaki, A.Yamaguchi, H.Nanbu, A.Shinagawa, M.Fukushima, M.Orisaka, Y.Yoshida
  Low-Grade Uterine Adenosarcoma with Overexpression of MDM2 and CDK4 by Immunohistochemistry: A Case Repoet and Literaturu Review
  Case Rep Oncol. 2024Oct25 17(1) p1229-1238
• M.Yumiko, M.Hosokawa, S.Kudo, T.Onuma, M.Orisaka, Y.Yoshida
  Postpartum multiple vertebral fractures in a patient with osteogenesis imperfecta type I: A case report and literature review
  Case Rep Womens Health 2024.Nov 16(44) e00666